|Poised epigenetic states and acquired drug resistance in cancer|
R Brown, E Curry, L Magnani, CS Wilhelm-Benartzi, J Borley
Nature Reviews Cancer 14 (11), 747-753, 2014
|PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer|
L Magnani, EB Ballantyne, X Zhang, M Lupien
PLoS genet 7 (11), e1002368, 2011
|Pioneer factors: directing transcriptional regulators within the chromatin environment|
L Magnani, J Eeckhoute, M Lupien
Trends in Genetics 27 (11), 465-474, 2011
|Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer|
L Magnani, A Stoeck, X Zhang, A Lánczky, AC Mirabella, TL Wang, ...
Proceedings of the National Academy of Sciences 110 (16), E1490-E1499, 2013
|Guidelines for the selection of functional assays to evaluate the hallmarks of cancer|
O Menyhárt, H Harami-Papp, S Sukumar, R Schäfer, L Magnani, ...
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1866 (2), 300-319, 2016
|Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer|
A Harrod, J Fulton, VTM Nguyen, M Periyasamy, L Ramos-Garcia, CF Lai, ...
Oncogene 36 (16), 2286-2296, 2017
|Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion|
VTM Nguyen, I Barozzi, M Faronato, Y Lombardo, JH Steel, N Patel, ...
Nature communications 6 (1), 1-14, 2015
|APOBEC3B-mediated cytidine deamination is required for estrogen receptor action in breast cancer|
M Periyasamy, H Patel, CF Lai, VTM Nguyen, E Nevedomskaya, A Harrod, ...
Cell reports 13 (1), 108-121, 2015
|Spearhead nanometric field-effect transistor sensors for single-cell analysis|
Y Zhang, J Clausmeyer, B Babakinejad, A López Córdoba, T Ali, ...
Acs Nano 10 (3), 3214-3221, 2016
|Brg1 is required for Cdx2-mediated repression of Oct4 expression in mouse blastocysts|
K Wang, S Sengupta, L Magnani, CA Wilson, RW Henry, JG Knott
PloS one 5 (5), e10622, 2010
|Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells|
Y Lombardo, M Faronato, A Filipovic, V Vircillo, L Magnani, RC Coombes
Breast cancer research 16 (3), 1-14, 2014
|In vitro and in vivo derived porcine embryos possess similar, but not identical, patterns of Oct4, Nanog, and Sox2 mRNA expression during cleavage development|
L Magnani, RA Cabot
Molecular Reproduction and Development: Incorporating Gamete Research 75 (12 …, 2008
|TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression|
S Ottaviani, J Stebbing, AE Frampton, S Zagorac, J Krell, A de Giorgio, ...
Nature communications 9 (1), 1-18, 2018
|Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer|
L Magnani, G Frige, RM Gadaleta, G Corleone, S Fabris, H Kempe, ...
Nature genetics 49 (3), 444-450, 2017
|Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer|
DK Patten, G Corleone, B Győrffy, Y Perone, N Slaven, I Barozzi, E Erdős, ...
Nature medicine 24 (9), 1469-1480, 2018
|Expression of CDK7, cyclin H, and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor–positive breast cancer|
H Patel, R Abduljabbar, CF Lai, M Periyasamy, A Harrod, C Gemma, ...
Clinical Cancer Research 22 (23), 5929-5938, 2016
|Chromatin and epigenetic determinants of estrogen receptor alpha (ESR1) signaling|
L Magnani, M Lupien
Molecular and cellular endocrinology 382 (1), 633-641, 2014
|LRH-1 governs vital transcriptional programs in endocrine-sensitive and-resistant breast cancer cells|
S Bianco, M Brunelle, M Jangal, L Magnani, N Gévry
Cancer research 74 (7), 2015-2025, 2014
|Differential remodeling of mono‐and trimethylated H3K27 during porcine embryo development|
KE Park, L Magnani, RA Cabot
Molecular Reproduction and Development: Incorporating Gamete Research 76 (11 …, 2009
|Dickkopf-3 links HSF1 and YAP/TAZ signalling to control aggressive behaviours in cancer-associated fibroblasts|
N Ferrari, R Ranftl, I Chicherova, ND Slaven, E Moeendarbary, ...
Nature communications 10 (1), 1-17, 2019